LncRNA SOX2OT improves insulin resistance in type 2 diabetes with sleep disorders by activating IRS/PI3K/AKT and suppressing oxidative stress and inflammation through the miR-552-5p/SOX2 axis
General physiology and biophysics · 2025 · 44 (06) · 495-507
DOI: 10.4149/gpb_2025035 ↗At a glance
Journal article in General physiology and biophysics, 2025. Written by Yalan Wang and 6 co-authors. Institution: Department of Endocrinology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuchang District, Wuhan, China. Major MEDLINE topics: RNA, Long Noncoding, Insulin Resistance, Diabetes Mellitus, Type 2, Sleep Apnea, Obstructive. Cited 1 times so far (Crossref).
Topics: Diabetes mellitus
Abstract (original language)
Obstructive sleep apnoea (OSA) and type 2 diabetes mellitus (T2DM) frequently co-occur, with long noncoding RNAs (lncRNAs) implicated in their shared pathophysiology (T2DM-OSA). LncRNA sex determining region Y-box protein 2 (SOX2) overlapping transcript (SOX2OT) is downregulated in diabetic models. This study investigated SOX2OT's regulatory roles using in vivo and in vitro T2DM-OSA models. Intermittent hypoxia (IH) and high glucose (HG) significantly suppressed SOX2OT expression in murine systems and HepG2 hepatocytes. SOX2OT overexpression enhanced glucose consumption and uptake in HG/IH-treated cells by activating insulin receptor substrate/phosphatidylinositol 3-kinase/protein kinase B (IRS/PI3K/AKT) signaling. Concurrently, SOX2OT attenuated oxidative stress (reactive oxygen species (ROS), malondialdehyde (MDA)) while elevating antioxidant activity (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px)), and suppressed inflammatory cytokines (tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β)). Mechanistically, SOX2OT functioned as a competing endogenous RNA for microRNA-552-5p (miR-552-5p) to depress SOX2 expression. Crucially, SOX2 knockdown abolished SOX2OT-mediated cytoprotection. Thus, SOX2OT ameliorates insulin resistance in T2DM-OSA through IRS/PI3K/AKT activation and miR-552-5p/SOX2-mediated suppression of oxidative stress and inflammation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Endocrinology, Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuchang District, Wuhan, China.
- Wuhan Mental Health Center, Qiaokou District, Wuhan, China.
Cite
APA
Wang, Y., Zheng, L., Dai, J., Yang, X., Tang, F., Li, Y., & Lu, Y. (2025). LncRNA SOX2OT improves insulin resistance in type 2 diabetes with sleep disorders by activating IRS/PI3K/AKT and suppressing oxidative stress and inflammation through the miR-552-5p/SOX2 axis. General physiology and biophysics, 44(06), 495-507. https://doi.org/10.4149/gpb_2025035
Vancouver
Wang Y, Zheng L, Dai J, Yang X, Tang F, Li Y, et al. LncRNA SOX2OT improves insulin resistance in type 2 diabetes with sleep disorders by activating IRS/PI3K/AKT and suppressing oxidative stress and inflammation through the miR-552-5p/SOX2 axis. General physiology and biophysics. 2025;44(06):495-507. doi:10.4149/gpb_2025035
BibTeX
@article{Wang2025,
author = {Wang, Yalan and Zheng, Li and Dai, Jing and Yang, Xiaoshi and Tang, Feng and Li, Yan and Lu, Yu},
title = {LncRNA SOX2OT improves insulin resistance in type 2 diabetes with sleep disorders by activating IRS/PI3K/AKT and suppressing oxidative stress and inflammation through the miR-552-5p/SOX2 axis},
journal = {General physiology and biophysics},
year = {2025},
volume = {44},
number = {06},
pages = {495--507},
doi = {10.4149/gpb_2025035}
}
EUVIMED